Dizziness in Parkinson's May Be Due to Cerebral Hypoperfusion

This article originally appeared here.
Share this content:
Dizziness in Parkinson's May Be Due to Cerebral Hypoperfusion
Dizziness in Parkinson's May Be Due to Cerebral Hypoperfusion

MONDAY, April 17, 2017 (HealthDay News) -- Cerebral hypoperfusion contributes to dizziness in patients with Parkinson's disease (PD), even without orthostatic hypotension (OH), according to a study published online April 12 in the Journal of Clinical Ultrasound.

Jinse Park, M.D., from Inje University in Busan, South Korea, and colleagues conducted transcranial Doppler and blood pressure monitoring for 10 minutes during the head-up tilt test in PD patients with dizziness and OH (22 patients; group 1), PD patients with dizziness but no OH (23; group 2), PD patients without dizziness (11; group 3), and age-matched healthy controls (10; group 4).

The researchers found that group 1 showed a significantly higher change in mean blood pressure within three minutes after head-up tilting, compared to the other groups (P < 0.001). However, groups 3 and 4 showed a significantly smaller change in cerebral blood flow velocity in the middle cerebral artery than groups 1 and 2 (P < 0.01).

"Transcranial Doppler monitoring during head-up tilting may be a useful tool for evaluating dizziness in PD patients with or without OH," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths